Financial Data and Key Metrics Changes - For Q3 FY2025, revenue decreased by 38% to $8.4 million compared to $13.6 million in the prior year period [11] - For the nine months ended June 30, 2025, revenue decreased by 5% to $43.3 million compared to $45.7 million in the prior year period [11] - Net loss attributable to common stockholders for Q3 FY2025 was $18.3 million, compared to a loss of $2 million in the same period last year [14] - EBITDA for Q3 FY2025 was $19.2 million, compared to $1.3 million for Q3 FY2024 [16] - Cash and cash equivalents increased to $42.1 million as of June 30, 2025, from $3.2 million at the end of FY2024 [16] Business Line Data and Key Metrics Changes - Citrus harvest volumes for Q3 FY2025 were approximately 2.1 million pound solids, down from 4.3 million pound solids in Q3 FY2024 [11] - Land Management and other operations revenue increased by 5768% for Q3 FY2025, primarily due to increased rock and sand royalty income and sod sales [12] - The company completed its last major citrus harvest in April 2025, marking a shift away from capital-intensive citrus operations [5][18] Market Data and Key Metrics Changes - The company achieved $9.3 million from combined land and equipment sales in Q3 FY2025, with year-to-date land sales reaching $23.5 million, exceeding the original guidance of $20 million [6][20] - The estimated present value of near-term real estate development projects is between $335 million and $380 million, representing significant value from just 10% of land holdings [9] Company Strategy and Development Direction - The company is transitioning to a diversified land company model, focusing on land development and diversified usage strategies [5][18] - The approval of House Bill 4,041 for the Corkscrew Grove Stewardship District is a significant regulatory milestone that supports the company's development strategy [7][19] - The company is maintaining a balance between high-value property development and diversified agricultural operations [10][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to deliver enhanced long-term returns for shareholders, with expectations of approximately $20 million in adjusted EBITDA for FY2025 [20][21] - The company is positioned to end the fiscal year with at least $25 million in cash and sufficient liquidity to fund operations through FY2027 [20] Other Important Information - The company has no significant debt maturities until 2029, with total debt at $85.2 million and net debt at $43.2 million as of June 30, 2025 [17] Q&A Session Summary Question: Are you currently in discussions for additional land sales? - Management indicated that discussions are ongoing, but the timing for closing these transactions is uncertain, potentially rolling into FY2026 [25][26] Question: What are potential milestones to watch for regarding Corkscrew? - Management noted that external variables could affect the entitlement process, but they remain confident in the timeline for securing permits [27][28] Question: Will Alico partner with other groups on development? - Currently, Alico is handling the entitlement process independently, with no immediate need for partners, but they have options for future partnerships [29][30][31]

Lucid Diagnostics (LUCD) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Good morning, and welcome toSpeaker1theSpeaker0Lucid Diagnostics Second Quarter twenty twenty five Business Update Conference Call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question and answer session. Please note that this event is being recorded. I would now like to turn the conference over to Matt Reilly, Lucid Diagnostics' Senior Director of Investor Relations.Please ...

Gauzy (GAUZ) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Good morning, ladies and gentlemen, and welcome to the Gozi Second Quarter twenty twenty five Earnings Call Conference. This call is being recorded on Wednesday, 08/13/2025. I would now like to turn the conference over to Don Scott. Please go ahead.Speaker1Thank you, operator, and thank you, everyone, for joining us today. Hosting the call today are Galaxy's CEO and Co Founder, Eyal Pesho and CFO, Mayor Pellen. On this call, management w ...

SBC Medical Group Holdings (SBC) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0It's time, so we would like to begin. Thank you very much for taking time out of your very busy schedules now to join SVC Medical Group Holdings earnings call. Today, our CEO, Mr. Aikawa, and our Vice President, Mr. Yoshida, will present our second quarter results, business progress and capital policy.At the bottom of your screen, you will find a question box. If you have any questions, please enter them briefly and c ...

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $3.4 million, a decrease from $11.8 million in Q2 2024, primarily due to distributor transitions and lower investments in sales and marketing [17][19] - Gross profit for the second quarter was $2.5 million, or 74% of revenue, compared to $9 million, or 76% of revenue in the same period in 2024 [17] - Operating expenses decreased by 48% year-over-year, leading to an operating loss improvement of 26% compared to the prior year [16][19] Business Line Data and Key Metrics Changes - Clinics utilizing the combination approach for obesity management grew by 20% compared to 2024, indicating potential for future growth [15] - Sales and marketing expenses were reduced to $2.4 million from $6.7 million in Q2 2024, reflecting increased operational efficiency [18] - Research and development expenses decreased to $1.8 million from $4.3 million in Q2 2024, driven by cost reductions related to the Audacity trial [18] Market Data and Key Metrics Changes - The company is focusing on international markets where GLP-1s are less expensive, which is expected to drive adoption of the combination therapy [24][30] - The U.S. market presents a significant opportunity, with 40% of adults classified as obese, yet only 8 million currently using injectable obesity therapy [15] Company Strategy and Development Direction - The new strategy emphasizes metabolically healthy weight loss through combination therapy of the Allurion balloon and low-dose GLP-1s [6][7] - The company is transitioning away from distribution partners lacking access to accounts that can deliver comprehensive obesity care, focusing instead on high-performing accounts [9][10] - A term sheet was signed with a strategic partner to expand manufacturing capabilities and explore the development of a novel GLP-1 drug-eluting intragastric balloon [11] Management's Comments on Operating Environment and Future Outlook - Management acknowledges that the transition to the new strategy may cause short-term disruptions but believes it will lead to long-term growth [15][16] - The company is optimistic about the potential for FDA approval of its PMA submission, which could accelerate its U.S. market entry [37] - Management is confident that the combination therapy will establish a new standard of care in obesity management [21] Other Important Information - Cash and cash equivalents as of June 30, 2025, were $12.7 million, providing a runway for future operations [19] - The company anticipates recording charges of approximately $1.5 million related to the new strategic direction [16] Q&A Session Summary Question: How should we think about low-dose GLP-1s plus Allurion gastric balloon impacting overall costs for obesity care? - Management noted that GLP-1s are inexpensive internationally, and combining them with the Allurion program incurs minimal costs for patients, driving adoption [24][30] Question: Can you provide guidance on operating expenses for R&D and G&A? - Management indicated that R&D expenses of $1.8 million are appropriate for the near term, with overall operating expenses expected to decrease by approximately 50% due to restructuring [41][42] Question: What is the cash runway associated with the U.S. launch? - Management stated that cash needs will depend on the commercial strategy in the U.S., but they feel confident about the current cash position [45][46] Question: How will the new strategy impact reengagement with accounts in France? - Management expressed optimism that the combination therapy approach will positively impact reengagement with accounts in France, especially as GLP-1s become more accessible [51]

Okeanis Eco Tankers (ECO) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Welcome to OET's Second Quarter twenty twenty five Financial Results Presentation. We will begin shortly. Aristides Alefuzos, CEO and Ehraktis Varunis, CFO of Okeanis EcoTankers will take you through the presentation. And we're pleased to address any questions raised at the end of the call. I would like to advise you that this session is being recorded.Herak, please begin the presentation now.Speaker1Thank you. Welcome every ...

Similarweb (SMWB) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Greetings. Welcome to SimilarWeb's Second Quarter Fiscal twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation today. Please note, this conference is being recorded.I will now turn the conference over to Rami Myerson, Vice President, Investor Relations. Thank you. You may now begin.Speaker1Thank you, operator. Welcome everyone to ...

ARS Pharmaceuticals (SPRY) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Good morning and welcome to the ARS Pharmaceuticals Conference Call. At this time, all participants are in a listen only mode. After the company's prepared remarks, we'll open the line for questions. Please be advised that this conference is being recorded. I'll now turn the call over to Justin Chalka, Chief Business Officer.Please go ahead.Speaker1Good morning, and thank you for joining our second quarter twenty twenty fiv ...

Financial Data and Key Metrics Changes - Revenue for Q2 2025 increased by 22% year-over-year, reaching $96 million [7][16] - Recurring revenue grew by 32% year-over-year, accounting for 74% of total revenue [7][17] - Adjusted EBITDA was nearly $13 million, representing approximately 13% of total revenue, an increase of $4.5 million compared to the previous year [8][21] - Net income for the quarter was nearly $12 million, compared to a net loss of $3 million in the prior year [21][22] - Total transaction value increased by over 34% year-over-year, reaching nearly $1.6 billion [15] Business Line Data and Key Metrics Changes - Processing revenue grew by 35% to $43 million, driven by a 16% increase in the installed base of managed and connected devices [17][18] - Hardware revenue was $25 million, slightly higher than the prior year's quarter [18] - The installed base of managed and connected devices grew by 16% year-over-year, reaching almost 1.38 million devices [15][18] Market Data and Key Metrics Changes - The company is experiencing strong global demand, particularly in emerging segments such as EV chargers and smart coolers [9][10] - The customer base expanded by approximately 24% year-over-year, approaching 105,000 customers [15] Company Strategy and Development Direction - The company is focused on expanding its geographic footprint and gaining market share across core verticals [4][5] - Strategic partnerships, such as with Ortel Energy for EV charging solutions, are expected to drive future growth [10][11] - The company is pursuing both organic growth and strategic M&A to enhance its market position [13][50] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about near-term growth opportunities, driven by the ongoing shift from cash to digital payments [13] - The company reaffirmed its full-year 2025 guidance, expecting revenue growth of 30% to 35% [23][24] - Management highlighted the importance of customer retention and engagement, with a churn rate of under 3% annually [5][40] Other Important Information - The company has made significant acquisitions, including Innopropay and a majority stake in NICE Capital, to strengthen its position in Europe and enhance its embedded banking division [11][12] - The gross margin improved to 48.3%, up from 44.3% in the previous year, driven by higher recurring and hardware margins [19] Q&A Session Summary Question: How should we think about the larger opportunity in terms of EV as a percentage of revenue? - Management indicated that the EV market presents a significant growth opportunity, with partnerships expected to drive customer acquisition and revenue growth [26][30] Question: Can you talk about NRR and how you think it will trend over the next couple of years? - Management noted that NRR remains strong, driven by growth in service and processing, and highlighted the importance of emerging verticals [37][40] Question: Can you provide an update on your hospitality and retail initiatives? - Management reported strong demand in the retail sector and ongoing integration efforts in the hospitality space, particularly in Brazil [42][44] Question: What is the expected revenue contribution from M&A this year? - Management expects around $10 million in inorganic growth for the year, with ongoing efforts to complete additional acquisitions [48][50] Question: Can you elaborate on the competitive landscape for the new EV charging partnerships? - Management emphasized their first-mover advantage and technical expertise in the EV charging industry, which has facilitated recent partnerships [59][61]

Reed's (REED) Q2 2025 Earnings Call August 13, 2025 08:30 AM ET Speaker0Good morning, and welcome to Reed's Second Quarter twenty twenty five Earnings Conference Call for the Three and Six Months Ended 06/30/2025. My name is Dennis, and I'll be your conference call operator for today. We will have prepared remarks from Sir Wallace, Reed's Chief Executive Officer and Doug McCurdy, Reed's Chief Financial Officer. Following their remarks, they will take your questions. Before we begin, please take note of the ...